Johnson & Johnson (JNJ) capitalization

Current snapshot

Market Cap
$578.82B
2.41B shares × $240.45 · as of last filing 2026-03-29
Net Worth
$81.19B
Stockholders' equity · 2026-03-29
Enterprise Value
$618.71B
Market cap + debt − cash
Net Debt
$39.89B
Debt $61.94B − Cash $22.05B

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-28 $504.42B
FY'24 2024-12-29 $352.38B
FY'23 2023-12-31 $401.32B
FY'22 2023-01-01 $470.58B
FY'21 2022-01-02 $457.44B
FY'20 2021-01-03 $420.31B
FY'19 2019-12-29 $391.24B
FY'18 2018-12-30 $347.28B
FY'17 2017-12-31 $383.57B
FY'16 2017-01-01 $321.31B
FY'15 2016-01-03 $288.94B
FY'14 2014-12-28 $300.88B
FY'13 2013-12-29 $265.69B
FY'12 2012-12-30 $195.42B
FY'11 2012-01-01 $182.00B
FY'10 2011-01-02 $172.49B
FY'09 2010-01-03 $179.65B
FY'09 2008-12-28 $166.05B
FY'09 2007-12-30 $196.12B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-29 $587.95B
Q4'25 2025-12-28 $500.37B
Q3'25 2025-09-28 $436.44B
Q2'25 2025-06-29 $368.70B
Q1'25 2025-03-30 $396.80B
Q4'24 2024-12-29 $349.22B
Q3'24 2024-09-29 $391.86B
Q2'24 2024-06-30 $354.00B
Q1'24 2024-03-31 $384.42B
Q4'23 2023-12-31 $377.55B
Q3'23 2023-10-01 $397.12B
Q2'23 2023-07-02 $434.61B
Q1'23 2023-04-02 $403.85B
Q4'22 2023-01-01 $460.05B
Q3'22 2022-10-02 $434.75B
Q2'22 2022-07-03 $478.94B
Q1'22 2022-04-03 $475.14B
Q4'21 2022-01-02 $449.79B
Q3'21 2021-10-03 $429.24B
Q2'21 2021-07-04 $451.45B
Q1'21 2021-04-04 $435.20B
Q4'20 2021-01-03 $413.70B
Q3'20 2020-09-27 $388.81B
Q2'20 2020-06-28 $367.33B
Q1'20 2020-03-29 $328.96B
Q4'19 2019-12-29 $384.01B
Q3'19 2019-09-29 $343.35B
Q2'19 2019-06-30 $374.90B
Q1'19 2019-03-31 $377.27B
Q4'18 2018-12-30 $338.94B
Q3'18 2018-09-30 $376.87B
Q2'18 2018-07-01 $330.20B
Q1'18 2018-04-01 $350.09B
Q4'17 2017-12-31 $374.86B
Q3'17 2017-10-01 $355.93B
Q2'17 2017-07-02 $362.67B
Q1'17 2017-04-02 $343.07B
Q4'16 2017-01-01 $312.60B
Q3'16 2016-10-02 $329.04B
Q2'16 2016-07-03 $338.91B
Q1'16 2016-04-03 $306.15B
Q4'15 2016-01-03 $283.44B
Q3'15 2015-09-27 $255.46B
Q2'15 2015-06-28 $280.19B
Q1'15 2015-03-29 $283.56B
Q4'14 2014-12-28 $292.12B
Q3'14 2014-09-28 $306.77B
Q2'14 2014-06-29 $301.76B
Q1'14 2014-03-30 $280.11B
Q4'13 2013-12-29 $261.25B
Q3'13 2013-09-29 $249.89B
Q2'13 2013-06-30 $248.39B
Q1'13 2013-03-31 $233.08B
Q4'12 2012-12-30 $194.22B
Q3'12 2012-09-30 $194.20B
Q2'12 2012-07-01 $189.05B
Q1'12 2012-04-01 $183.03B
Q4'11 2012-01-01 $180.02B
Q3'11 2011-10-02 $176.94B
Q2'11 2011-07-03 $187.18B
Q1'11 2011-04-03 $164.95B
Q4'10 2011-01-02 $169.17B
Q3'10 2010-10-03 $172.06B
Q2'10 2010-07-04 $165.19B
Q1'10 2010-04-04 $183.98B
Q4'09 2010-01-03 $177.25B
Q3'09 2009-09-27 $169.31B
Q2'09 2009-06-28 $157.46B
Q1'10 2009-03-29 $147.39B
Q4'09 2008-12-28 $166.05B
Q3'09 2008-09-28 $196.49B
Q2'09 2008-06-29 $180.84B
Q4'09 2007-12-30 $196.12B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (JNJ CIK 0000200406), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

NUVB

Nuvation Bio Inc.

WPC

W. P. Carey Inc.

ENVX

Enovix Corporation